Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu Cheng

Showing results (741-750 of 768) with videos related to

Pageof 77
Sort By:
Journal of the Chinese Medical Association : JCMA|June 9, 2023
Surgical strategy for colorectal cancer with synchronous liver and extrahepatic metastases: A scoring system and decision tree modelChan-Wei Tseng, Hao-Wei Teng, Chun-Chi Lin, et al.
Clinical and Translational Medicine|September 29, 2021
Clinical and molecular features of Epstein-Barr virus-positive diffuse large B-cell lymphoma: Results in a multi-center trialChen Xing Zhao, Jing Jing Wen, Di Fu, et al.
Ebiomedicine|April 11, 2025
Molecular heterogeneity of CD30<sup>+</sup> peripheral T-cell lymphoma with prognostic significance and therapeutic implications: a retrospective multi-centre studyYu-Jia Huo, Shu Cheng, Hong-Mei Yi, et al.
Journal of Hepatology|September 19, 2025
Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker explorationYih-Jyh Lin, Da-Liang Ou, Yung-Yeh Su, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 5, 2020
MK-8719, a Novel and Selective <i>O</i>-GlcNAcase Inhibitor That Reduces the Formation of Pathological Tau and Ameliorates Neurodegeneration in a Mouse Model of TauopathyXiaohai Wang, Wenping Li, Jacob Marcus, et al.
American Journal of Human Genetics|June 17, 2026
Complete chromosome 21 centromere sequencing of families with Down syndromeF Kumara Mastrorosa, Alessia Daponte, Luciana de Gennaro, et al.
Molecular Biomedicine|December 9, 2025
Clinicopathological characteristics, genetic aberrations, and optimized treatment strategies in double-hit and triple-hit lymphoma: a multi-center cohort studyYi-Ge Shen, Meng-Meng Ji, Qing Shi, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 15, 2024
Extending the Grading of Recommendations Assessment, Development and Evaluation (GRADE) in Traditional Chinese Medicine (TCM): The GRADE-TCMQin-Wei Fu, Yang Liu, Shu-Cheng Chen, et al.
Liver Cancer|July 9, 2026
Addition of Intra-Arterial Therapy to Immunotherapy Improves Outcomes in Unresectable Hepatocellular Carcinoma: Taiwan Multicenter Cohort StudyTeng-Yu Lee, Pei-Chang Lee, Ying-Chun Shen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 5, 2003
Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United StatesAllan J Collins, Bertram Kasiske, Charles Herzog, et al.
Pageof 77

Showing results (741-750 of 768) with videos related to

Sort By:
Pageof 77
Journal of the Chinese Medical Association : JCMA|June 9, 2023
Surgical strategy for colorectal cancer with synchronous liver and extrahepatic metastases: A scoring system and decision tree modelChan-Wei Tseng, Hao-Wei Teng, Chun-Chi Lin, et al.
Clinical and Translational Medicine|September 29, 2021
Clinical and molecular features of Epstein-Barr virus-positive diffuse large B-cell lymphoma: Results in a multi-center trialChen Xing Zhao, Jing Jing Wen, Di Fu, et al.
Ebiomedicine|April 11, 2025
Molecular heterogeneity of CD30<sup>+</sup> peripheral T-cell lymphoma with prognostic significance and therapeutic implications: a retrospective multi-centre studyYu-Jia Huo, Shu Cheng, Hong-Mei Yi, et al.
Journal of Hepatology|September 19, 2025
Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker explorationYih-Jyh Lin, Da-Liang Ou, Yung-Yeh Su, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 5, 2020
MK-8719, a Novel and Selective <i>O</i>-GlcNAcase Inhibitor That Reduces the Formation of Pathological Tau and Ameliorates Neurodegeneration in a Mouse Model of TauopathyXiaohai Wang, Wenping Li, Jacob Marcus, et al.
American Journal of Human Genetics|June 17, 2026
Complete chromosome 21 centromere sequencing of families with Down syndromeF Kumara Mastrorosa, Alessia Daponte, Luciana de Gennaro, et al.
Molecular Biomedicine|December 9, 2025
Clinicopathological characteristics, genetic aberrations, and optimized treatment strategies in double-hit and triple-hit lymphoma: a multi-center cohort studyYi-Ge Shen, Meng-Meng Ji, Qing Shi, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 15, 2024
Extending the Grading of Recommendations Assessment, Development and Evaluation (GRADE) in Traditional Chinese Medicine (TCM): The GRADE-TCMQin-Wei Fu, Yang Liu, Shu-Cheng Chen, et al.
Liver Cancer|July 9, 2026
Addition of Intra-Arterial Therapy to Immunotherapy Improves Outcomes in Unresectable Hepatocellular Carcinoma: Taiwan Multicenter Cohort StudyTeng-Yu Lee, Pei-Chang Lee, Ying-Chun Shen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 5, 2003
Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United StatesAllan J Collins, Bertram Kasiske, Charles Herzog, et al.
Pageof 77